Changes in Polysomnography and Rhinomanometry Parameters After Rapid Maxillary Expansion or Adenotonsilectomy in Children With Obstructive Sleep Apnea
NCT ID: NCT07069543
Last Updated: 2025-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
51 participants
INTERVENTIONAL
2021-02-15
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: A sample of 51 children aged 5 to 10 years, diagnosed with OSA through PSG and referred for AT, was selected in a hospital based mouth-breathing specialized center. Children were divided in 2 groups: the AT group with 25 individuals, without maxillary hypoplasia, and the RME group composed of 26 children with maxillary constriction and posterior crossbite, with indication for RME before the AT surgery. Children underwent an initial evaluation at the time of selection (T0) and six months after the intervention: AT or RME (T1).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Maxillary Expansion Effects in Children With Upper Airway Obstruction
NCT03004300
Effect of CPAP and Adenotonsillectomy in Upper Airway Volume of Children With OSAS
NCT03169491
Cold Versus Hot Adenoidectomy for Obstructive Sleep Apnea in Pediatric Patients
NCT03760341
Comparison of Two Reeducation Methods in Children With Persistent Sleep Apnea, a Randomized Controlled Trial
NCT06634264
Multi-disciplinary Diagnosis and Treatment Process and Evaluation System for Children With Sleep Disordered Breathing and Malocclusion
NCT03451318
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adenotonsillectomy group
adenotonsillectomy surgical group
Adenotonsillectomy
the adenotonsillectomy group children, indicated for immediate adenotonsillectomy
Rapid maxillary expansion group
rapid maxillary expansion group
Rapid maxillary expansion
expansion group children with a narrow palate and posterior crossbite, with indication for rapid maxillary expansion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adenotonsillectomy
the adenotonsillectomy group children, indicated for immediate adenotonsillectomy
Rapid maxillary expansion
expansion group children with a narrow palate and posterior crossbite, with indication for rapid maxillary expansion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* between 5 and 10 years of age
* Indication for adenotonsillectomy (adenoids occupying more than 75% of the nasopharynx and/or tonsils classified as degree 3 or 4)
Exclusion Criteria
* craniofacial syndromes that interfered with functional and psychosocial development,
* children who did not complete the expansion
* parents did not sign the informed consent
5 Years
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of Minas Gerais
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mariana Maciel Tinano
Associate Professor, Outpatient clinic for the Mouth-breathers,
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federal University of Minas Gerais
Belo Horizonte, Minas Gerais, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COEP/UFMG number 51038721.7.00
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.